Research Association

The Kinder PPH (now “Lungenkinder”) research association was brought into being in 1999 by Gerald Fischer and he heads it to this day. When Gerald Fischer’s daughter Maleen was 3 years old, she was finally diagnosed with idiopathic pulmonary-arterial hypertension, in other words pulmonary hypertension, after her condition had baffled doctors for a long time. Since there were not yet any treatment options in Austria at the time, Maleen Fischer was sent home as a terminally ill patient with a life expectancy of just 2 to 3 years. The family was not prepared to accept this. Gerald Fischer found help in New York at the Columbia University Presbyterian Hospital, a research and treatment centre directed by Dr. Robyn Barst, where the research had already progressed considerably further. Since that time, his daughter has received her life-supporting medicine intravenously via a permanent cannula. When he asked Dr. Robyn Barst why there was still no cure, Gerald Fischer received the reply that there were too few patients to motivate big pharmaceutical companies to undertake the intensive research. “Give me 10 million dollars and I will find you a cure in 3 years!” was what she said at the time.
A sum of 10 million dollars is, of course, not so easy to find, but founding the Research Association was intended to be a start. Since then, Gerald Fischer has been trying to generate money for research by means of charity events and has already been able to provide financial support to many research projects.

Annual Report 2018
Finance Report 2018

Annual Report 2017
Finance Report 2017

Donations favoring decision
Donation seal of approval

Applies to the “Lungenkinder” Research Association

Responsible person for charity advertisment, usage and data protection: Gerald Fischer



Zurück zur Startseite